Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Bristol-Myers Squibb is a differentiated company, led by our unique BioPharma strategy that leverages the reach and resources of a major pharma company paired with the entrepreneurial spirit and agility of a biotech firm. We work every day to deliver innovative medicines for patients with serious and life-threatening diseases.
Each day, our employees around the world work together for patients – it drives everything we do. We are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. Through our R&D organisation, we have built a sustainable pipeline of potential therapies, and actively partner to access external innovation to broaden and accelerate our work.
As global citizens, we work sustainably, responsibly and seek to give back. Through the Bristol-Myers Squibb Foundation, we promote health equity and strive to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people.
Merck, sağlık hizmetleri, yaşam bilimleri ve performans materyalleri alanlarında önde gelen bilim ve teknoloji şirketidir. 50.000 civarındaki çalışanı, kanser ya da multiple skleroz için biyofarmasötik tedavilerden bilimsel araştırmalar için çığır açan yeni teknolojilere, akıllı telefonlarda ve LCD televizyonlarda kullanılan sıvı kristal ekranlara kadar çeşitli alanlarda hayatı kolaylaştıran yeni teknolojiler geliştirmek için çalışmaktadır. 1668’de kurulmuş olan Merck, dünyanın en eski ilaç ve kimya şirketidir. Kurucu aile üyeleri şirketin halen çoğunluk hisselerine sahiplerdir.
Merck, Merck isminin ve markasının dünya genelinde haklarına sahiptir. Bu durumun tek istisnası olan Birleşik Devletler’de ve Kanada’da şirket, EMD Serono, MilliporeSigma ve EMD Performans Materyalleri isimleriyle faaliyet göstermektedir.
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer's disease and infectious diseases including HIV and Ebola.